{"entity":{"id":"nct02686944","kind":"trial","name":"A Study to Evaluate the Safety of Intuvax Administered Intra-tumorally in Patients With Gastrointestinal Stromal Tumors","aka":[],"tldr":"A phase 1 trial of Ilixadencel run by Mendus, completed.","summary":"A Study to Evaluate the Safety of Intuvax Administered Intra-tumorally in Patients With Gastrointestinal Stromal Tumors is a phase 1 interventional study registered as NCT02686944 by Mendus, with 6 participants enrolled, started 2016-06-01. Conditions recorded: Gastrointestinal Stromal Tumor. Interventions recorded: Intuvax (ilixadencel).","status":"completed","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT02686944","url":"https://clinicaltrials.gov/study/NCT02686944"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["gist"],"sections":[],"technologies":[],"targets":[],"drugs":["ilixadencel"],"companies":["mendus"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT02686944","phase":"1","setting":"A Phase I Open-label Study Evaluating Safety and Efficacy of Intratumorally Administered Intuvax in Patients With Progressing Gastrointestinal Stromal Tumors (GIST) During Ongoing Second, Third or Fourth Line Treatment With Tyrosine Kinase Inhibition Therapy. A Prospective Single Armed, Open Label Phase I Safety and Efficacy Study","sponsor":"Mendus","enrolled":6,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct02686944/","neighbours":{"cancer":[{"id":"gist","kind":"cancer","name":"Gastrointestinal stromal tumour (GIST)","route":"/cancers/gist/"}],"drug":[{"id":"ilixadencel","kind":"drug","name":"Ilixadencel","route":"/drugs/ilixadencel/"}],"company":[{"id":"mendus","kind":"company","name":"Mendus","route":"/companies/mendus/"}]}}